Patent · US Active

Single lentiviral vector system for induced pluripotent (iPS) stem cells derivation

US8865467B2 · kind B2 · utility

1Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 6, 2011
Grant dateOct 21, 2014
Priority date
Expiry dateJun 21, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2840/203
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention is based on the discovery that a single lentiviral vector expressing multiple individual transcription factor proteins from a single multi-cistronic mRNA can reprogram a fibroblast cell to a stem cell-like cell. These reprogrammed induced pluripotent stem (iPS) cells are pluripotent. Additions of the Cre-LoxP sequences into the single lentiviral vector facilitate excision of the vector after reprogramming in achieved. Addition of a maker gene into the single lentiviral vector facilitates detection of the presence of the vector in an iPS. The invention provides compositions and methods of producing iPS cells using a single multi-cistronic lentiviral vector.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.